A nice example of #BullousPemphigoid with linear deposition of C3 on #IMF
#pathology
#dermatology
#PathSky
😉
#pathology
#dermatology
#PathSky
😉
February 11, 2025 at 8:06 PM
A nice example of #BullousPemphigoid with linear deposition of C3 on #IMF
#pathology
#dermatology
#PathSky
😉
#pathology
#dermatology
#PathSky
😉
From the November issue: Homing in on BP180 epitopes in #bullouspemphigoid https://ow.ly/HEsE50X6eyG #medderm #dermsky
December 11, 2025 at 11:10 AM
From the November issue: Homing in on BP180 epitopes in #bullouspemphigoid https://ow.ly/HEsE50X6eyG #medderm #dermsky
Explore expert-led #CME on bullous pemphigoid, featuring new insights into disease biology and treatment.
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
January 8, 2026 at 9:00 PM
Explore expert-led #CME on bullous pemphigoid, featuring new insights into disease biology and treatment.
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
The long list of therapeutic uses for #Sanofi and #Regeneron's #Dupixent has been lengthened, after the drug became the first FDA-approved therapy for rare and debilitating #skindisease #bullouspemphigoid.
Dupixent is first FDA-approved drug for rare skin disease
The long list of therapeutic uses for Sanofi and Regeneron's Dupixent has been lengthened by an FDA approval for rare skin disease bullous pemphigoid.
buff.ly
June 20, 2025 at 1:30 PM
The long list of therapeutic uses for #Sanofi and #Regeneron's #Dupixent has been lengthened, after the drug became the first FDA-approved therapy for rare and debilitating #skindisease #bullouspemphigoid.
New findings suggest that while serum IL-13 levels are lower in patients with #BullousPemphigoid compared to healthy controls, IL-13 levels do not correlate with bullous pemphigoid severity or prognosis.
View more: www.hcplive.com/view...
View more: www.hcplive.com/view...
Study Highlights Complex Role of IL-13 Among Patients with Bullous Pemphigoid
This analysis suggests serum IL-13 levels are lower in bullous pemphigoid patients than in healthy controls and pemphigus vulgaris patients.
www.hcplive.com
July 16, 2025 at 2:00 PM
New findings suggest that while serum IL-13 levels are lower in patients with #BullousPemphigoid compared to healthy controls, IL-13 levels do not correlate with bullous pemphigoid severity or prognosis.
View more: www.hcplive.com/view...
View more: www.hcplive.com/view...
From the May issue: A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis https://ow.ly/YO2450YMAIl #S100A8 #BullousPemphigoid #AtopicDermatitis #medderm #dermsky
June 9, 2026 at 3:40 PM
From the May issue: A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis https://ow.ly/YO2450YMAIl #S100A8 #BullousPemphigoid #AtopicDermatitis #medderm #dermsky
A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis https://ow.ly/u5Zu50YMAIm #S100A8 #BullousPemphigoid #AtopicDermatitis #medderm #dermsky
April 23, 2026 at 11:15 AM
A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis https://ow.ly/u5Zu50YMAIm #S100A8 #BullousPemphigoid #AtopicDermatitis #medderm #dermsky
From the March 2026 issue: Association of #immunecheckpointinhibitor induced #bullouspemphigoid with underlying cancer type: a lack of association with cancer tissue #COL17A1 mutations and dysregulation https://ow.ly/zNhA50Yzb4J #dermatology #dermsky
April 17, 2026 at 6:55 PM
From the March 2026 issue: Association of #immunecheckpointinhibitor induced #bullouspemphigoid with underlying cancer type: a lack of association with cancer tissue #COL17A1 mutations and dysregulation https://ow.ly/zNhA50Yzb4J #dermatology #dermsky
Association of #immunecheckpointinhibitor induced #bullouspemphigoid with underlying cancer type: a lack of association with cancer tissue #COL17A1 mutations and dysregulation https://www.jidinnovations.org/article/S2667-0267(26)00001-9/fulltext #dermatology #dermsky
January 20, 2026 at 2:50 PM
Association of #immunecheckpointinhibitor induced #bullouspemphigoid with underlying cancer type: a lack of association with cancer tissue #COL17A1 mutations and dysregulation https://www.jidinnovations.org/article/S2667-0267(26)00001-9/fulltext #dermatology #dermsky
October 9, 2025 at 3:15 PM